Aptah Bio
PrivateLast Round
Seed
Dec 24, 2024
Total Funding Raised
$18M
Company Overview
Aptah Bio is a biotechnology company that develops first-in-class RNA therapeutics targeting U1 snRNP dysfunction to slow tumor evolution, reduce cancer heterogeneity, and overcome adaptive resistance in glioblastoma and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptah Bio Comps
Public and private peers based on sector, stage, and business model.
Aptah Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 24, 2024 | ||||
| Series A | Aug 14, 2023 | ||||
| Accelerator | Aug 26, 2021 |
Key People
Founding team and executive leadership
Aptah Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taihill Venture | Seed |
| 5Y Capital | Seed |
| K2VC | Seed |
| MBC BioLabs | Accelerator, Series A |
| UpHonest Capital | Seed |
| Financiadora de Estudos e Projetos | Series A |
| Mission BioCapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2025
Monthly visitors increased 31% MoM.
- Feb 26, 2025
Monthly visitors increased 946% MoM, reaching 502.
Aptah Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aptah Bio's valuation, stock price, and market status.
